MiNK Therapeutics (INKT) Q1 2025 Earnings

18MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.8
-0.56
-0.31
-0.07

Details

Expected EPS
-0.486667
Actual EPS
-0.62
Surprise EPS
-0.13
Surprise Percent
+27.4%

Description

MiNK Therapeutics (INKT) has reported earnings of -0.62 per share for Q1 2025.

0 Comments

Share your thoughts